7.6K(top 0.1%)
papers
233.0K(top 0.1%)
citations
187(top 0.1%)
h-index
313(top 0.1%)
g-index
8.8K
all documents
253.3K
doc citations
11.7K
citing journals

Top Articles

#TitleJournalYearCitations
1Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet, The20126,376
2Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trialLancet, The20165,456
3Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelBlood20174,375
4Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood20102,963
5Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyLancet Oncology, The20102,093
6AtherosclerosisNature Reviews Disease Primers20191,601
7Characteristics and Outcomes in Adult Patients Receiving Mechanical Ventilation<SUBTITLE>A 28-Day International Study</SUBTITLE>JAMA - Journal of the American Medical Association20021,398
8Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 casesBritish Journal of Dermatology20201,030
9Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular AnomaliesPediatrics20151,026
10Morphine and alternative opioids in cancer pain: the EAPC recommendationsBritish Journal of Cancer2001759
11Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failureJournal of Hepatology2014741
12Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialLancet, The2013688
13Associative Processes in Addiction and Reward The Role of Amygdala‐Ventral Striatal SubsystemsAnnals of the New York Academy of Sciences1999674
14Uterine sarcomas: A reviewGynecologic Oncology2010659
1510 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extensionLancet Diabetes and Endocrinology,the2017635
16Cystatin C as a marker of GFR—history, indications, and future researchClinical Biochemistry2005606
17Cerebral State Index during Propofol AnesthesiaAnesthesiology2006598
18Grading quality of evidence and strength of recommendations in clinical practice guidelinesAllergy: European Journal of Allergy and Clinical Immunology2009596
19Growth Characteristics of Infantile Hemangiomas: Implications for ManagementPediatrics2008583
20Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac SurgeryJAMA - Journal of the American Medical Association2017579
21Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trialAnnals of the Rheumatic Diseases2014576
22Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid ConditionsJournal of Investigative Dermatology2010554
23Epidemiology of atopic dermatitis in adults: Results from an international surveyAllergy: European Journal of Allergy and Clinical Immunology2018546
24Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized StudyGastroenterology2008541
25Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 studyLancet Oncology, The2016533
26Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Drug and Alcohol Dependence2011532
27Prospective Study of Infantile Hemangiomas: Clinical Characteristics Predicting Complications and TreatmentPediatrics2006527
28Clinical picture and risk prediction of short‐term mortality in cardiogenic shockEuropean Journal of Heart Failure2015520
29Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003Journal of Clinical Microbiology2005505
30HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjectsNature Medicine2010500
31Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19JAMA - Journal of the American Medical Association2021498
32Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosisHepatology2015493
33Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa InfectionsClinical Microbiology Reviews2019489
34Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trialsEuropean Journal of Cancer2012485
35Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trialLancet Oncology, The2020475
36Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyLancet Neurology, The2017472
37Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus ConferencePediatrics2013469
38Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trialsLancet, The2018457
39Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trialLancet Oncology, The2019448
40Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological featuresVirchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin2012442
41Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM studyBlood2012429
42Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis SurveyJournal of the American Academy of Dermatology2014423
43Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemiaBlood2013420
44Role of vitamin D in the pathogenesis of type 2 diabetes mellitusDiabetes, Obesity and Metabolism2008410
45Prospective Study of Infantile Hemangiomas: Demographic, Prenatal, and Perinatal CharacteristicsJournal of Pediatrics2007408
46Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohortLancet Oncology, The2014406
47A critical role for elastin signaling in vascular morphogenesis and diseaseDevelopment (Cambridge)2003400
48Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian CancerJAMA - Journal of the American Medical Association2015390
49Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutationsHuman Mutation2008382
50Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trialLancet, The2018373